Literature DB >> 28578482

High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients.

Yongxiang Yang1,2,3, Min Zhang1, Yuqin Ye2,4, Shan Ma5, Lingling Fan5, Zhuyi Li6.   

Abstract

Recent studies show that the frequencies of circulating follicullar helper T (cTfh) cells are significantly higher in myasthenia gravis (MG) patients compared with healthy controls (HC). And, they are positively correlated with levels of serum anti-acetylcholine receptor antibody (anti-AchR Ab). It is unclear whether cTfh cell subset frequencies are altered and what role they play in MG patients. In order to clarify this, we examined the frequencies of cTfh cell counterparts, their subsets, and circulating plasmablasts in MG patients by flow cytometry. We determined the concentrations of serum anti-AChR Ab by enzyme-linked immunosorbent assay (ELISA). We assayed the function of cTfh cell subsets by flow cytometry and real-time polymerase chain reaction (RT-PCR). We found higher frequencies of cTfh cell counterparts, cTfh-Th17 cells, and plasmablasts in MG patients compared with HC. The frequencies of cTfh cell counterparts and cTfh-Th17 cells were positively correlated with the frequencies of plasmablasts and the concentrations of anti-AChR Ab in MG patients. Functional assays showed that activated cTfh-Th17 cells highly expressed key molecular features of Tfh cells including ICOS, PD-1, and IL-21. Results indicate that, just like cTfh cell counterparts, cTfh-Th17 cells may play a role in the immunopathogenesis and the production of anti-AChR Ab of MG.

Entities:  

Keywords:  Anti-acetylcholine receptor antibody; Circulating follicular helper T cell; Myasthenia gravis; Plasmablasts

Mesh:

Substances:

Year:  2017        PMID: 28578482     DOI: 10.1007/s10072-017-3009-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  39 in total

1.  ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6.

Authors:  Youn Soo Choi; Robin Kageyama; Danelle Eto; Tania C Escobar; Robert J Johnston; Laurel Monticelli; Christopher Lao; Shane Crotty
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

2.  Clinical outcome and predictive factors of irradiation-associated myasthenia gravis exacerbation in thymomatous patients.

Authors:  Yan Li; Pei Chen; Li Ding; Chuanming Luo; Haiyan Wang; Zhenguang Chen; Chunhua Su; Huiyu Feng; Xin Huang; Weixiong Xia; Weibin Liu
Journal:  Neurol Sci       Date:  2015-07-26       Impact factor: 3.307

3.  Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers.

Authors:  Salah-Eddine Bentebibel; Nathalie Schmitt; Jacques Banchereau; Hideki Ueno
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

4.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity.

Authors:  Carola G Vinuesa; Matthew C Cook; Constanza Angelucci; Vicki Athanasopoulos; Lixin Rui; Kim M Hill; Di Yu; Heather Domaschenz; Belinda Whittle; Teresa Lambe; Ian S Roberts; Richard R Copley; John I Bell; Richard J Cornall; Christopher C Goodnow
Journal:  Nature       Date:  2005-05-26       Impact factor: 49.962

5.  Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility.

Authors:  Heping Xu; Xuanying Li; Dan Liu; Jianfu Li; Xu Zhang; Xin Chen; Shiyue Hou; Lixia Peng; Chenguang Xu; Wanli Liu; Lianfeng Zhang; Hai Qi
Journal:  Nature       Date:  2013-04-25       Impact factor: 49.962

6.  IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism.

Authors:  Dimitra Zotos; Jonathan M Coquet; Yang Zhang; Amanda Light; Kathy D'Costa; Axel Kallies; Lynn M Corcoran; Dale I Godfrey; Kai-Michael Toellner; Mark J Smyth; Stephen L Nutt; David M Tarlinton
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

Review 7.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

8.  Clinical predictors for the prognosis of myasthenia gravis.

Authors:  Lili Wang; Yun Zhang; Maolin He
Journal:  BMC Neurol       Date:  2017-04-19       Impact factor: 2.474

9.  Follicular helper T cells are required for systemic autoimmunity.

Authors:  Michelle A Linterman; Robert J Rigby; Raphael K Wong; Di Yu; Robert Brink; Jennifer L Cannons; Pamela L Schwartzberg; Matthew C Cook; Giles D Walters; Carola G Vinuesa
Journal:  J Exp Med       Date:  2009-02-16       Impact factor: 14.307

10.  Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.

Authors:  Jeppe Romme Christensen; Lars Börnsen; Rikke Ratzer; Fredrik Piehl; Mohsen Khademi; Tomas Olsson; Per Soelberg Sørensen; Finn Sellebjerg
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more
  9 in total

Review 1.  Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.

Authors:  Grayson Beecher; Brendan Nicholas Putko; Amanda Nicole Wagner; Zaeem Azfer Siddiqi
Journal:  Drugs       Date:  2019-03       Impact factor: 9.546

2.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

3.  Immune Skew of Circulating Follicular Helper T Cells Associates With Myasthenia Gravis Severity.

Authors:  Shinji Ashida; Hirofumi Ochi; Mio Hamatani; Chihiro Fujii; Kimitoshi Kimura; Yoichiro Okada; Yuichiro Hashi; Kazuyuki Kawamura; Hideki Ueno; Ryosuke Takahashi; Toshiki Mizuno; Takayuki Kondo
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-01-12

Review 4.  T Follicular Helper Cells in Autoimmune Disorders.

Authors:  Noémie Gensous; Manon Charrier; Dorothée Duluc; Cécile Contin-Bordes; Marie-Elise Truchetet; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco; Christophe Richez
Journal:  Front Immunol       Date:  2018-07-17       Impact factor: 7.561

5.  CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.

Authors:  Merve Çebi; Hacer Durmus; Fikret Aysal; Berker Özkan; Gizem Engin Gül; Arman Çakar; Mehmet Hocaoglu; Metin Mercan; Sibel P Yentür; Melih Tütüncü; Vildan Yayla; Onur Akan; Öner Dogan; Yeşim Parman; Güher Saruhan-Direskeneli
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

6.  The Transcription Factor T-Bet Is Required for Optimal Type I Follicular Helper T Cell Maintenance During Acute Viral Infection.

Authors:  Pengcheng Wang; Youping Wang; Luoyingzi Xie; Minglu Xiao; Jialin Wu; Lifan Xu; Qiang Bai; Yaxing Hao; Qizhao Huang; Xiangyu Chen; Ran He; Baohua Li; Sen Yang; Yaokai Chen; Yuzhang Wu; Lilin Ye
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

7.  Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis.

Authors:  Ting Chang; Chunxiao Niu; Chao Sun; Ying Ma; Rongjing Guo; Zhe Ruan; Yanwu Gao; Xiaodan Lu; Huanhuan Li; Ye Lin; Jiaji Lin; Zhuyi Li
Journal:  Aging (Albany NY)       Date:  2020-11-02       Impact factor: 5.682

8.  Two types of immune infiltrating cells and six hub genes can predict the occurrence of myasthenia gravis in patients with thymoma.

Authors:  Ziyou Tao; Chao Lu; Shuai Gao; Peng Zhang; Yuan Chen; Yuanguo Wang; Zhaoyu Yang; Kai Xiong; Yuxin Liu; Peng Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Act1 is a negative regulator in T and B cells via direct inhibition of STAT3.

Authors:  Cun-Jin Zhang; Chenhui Wang; Meiling Jiang; Chunfang Gu; Jianxin Xiao; Xing Chen; Bradley N Martin; Fangqiang Tang; Erin Yamamoto; Yibo Xian; Han Wang; Fengling Li; R Balfour Sartor; Howard Smith; M Elaine Husni; Fu-Dong Shi; Ji Gao; Julie Carman; Ashok Dongre; Susan C McKarns; Ken Coppieters; Trine N Jørgensen; Warren J Leonard; Xiaoxia Li
Journal:  Nat Commun       Date:  2018-07-16       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.